The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

World shares are mixed after U.S. stocks capped a mostly dismal week with a broad rally. Shares prices of Honda and Nissan ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance ...

Novo Nordisk's CagriSema shows 22.7% weight loss in Phase 3 trials, while tolerability concerns grow. MariTide offers ...

Novo Nordisk's CagriSema Phase 3 data showed 22.7% weight loss, missing the company's own 25% target, causing a 20% drop in ...

Duty Free Meds is proud to introduce a new Zepbound coupon offering to help lower patient costs associated with the weight-loss medication. These coupons can help customers spend less on weight-loss ...

Square Enix has surprised us at The Game Awards 2024 with a PC release date for Final Fantasy 7 Rebirth - and it's really soon. The PC version of the second Final Fantasy 7 remake trilogy arrives ...